Atsunori Kusakabe

Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection

Kentaro Matsuura, Hiromi Sawai, Kazuho Ikeo et al. · Gastroenterology · 2017 · 138 citations

Life Sciences, Genetics, Molecular Genetics +17

Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group

Toshie Mashiba, Kouji Joko, Masayuki Kurosaki et al. · PLoS ONE · 2018 · 56 citations · Full text

Medicine, Oncology, Cancer Control +16

The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study

Kaoru Tsuchiya, Masayuki Kurosaki, Azusa Sakamoto et al. · Cancers · 2021 · 56 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular carcinoma

Hironori Ochi, Masayuki Kurosaki, Kouji Joko et al. · Hepatology Research · 2022 · 45 citations · Full text

Medicine, Oncology, Pharmacology +12

Efficacy of daclatasvir/asunaprevir according to resistance-associated variants in chronic hepatitis C with genotype 1

Etsuko Iio, Noritomo Shimada, Hiroshi Abe et al. · Journal of Gastroenterology · 2016 · 43 citations

Life Sciences, Genetics, Pharmacotherapy +16